| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 21 | |
| #2 | China | 4 | |
| #3 | United Kingdom | 3 | |
| #4 | Honduras | 3 | |
| #5 | Uruguay | 3 | |
| #6 | Ecuador | 2 | |
| #7 | Israel | 2 | |
| #8 | WIPO (World Intellectual Property Organization) | 2 | |
| #9 | South Africa | 2 | |
| #10 | Costa Rica | 1 | |
| #11 | Egypt | 1 | |
| #12 | Iceland | 1 | |
| #13 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Medical technology | |
| #4 | Environmental technology | |
| #5 | Packaging and shipping | |
| #6 | Biotechnology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Butterworth Sam | 3 |
| #2 | Pass Martin | 3 |
| #3 | Griffen Edward Jolyon | 3 |
| #4 | Wang Tao | 2 |
| #5 | Gibson Keith Hopkinson | 2 |
| #6 | Berry Simon | 2 |
| #7 | Bradbury Robert Hugh | 2 |
| #8 | James Kang | 2 |
| #9 | Foote Kevin Michael | 2 |
| #10 | Wang Haixia | 2 |
| Publication | Filing date | Title |
|---|---|---|
| GB201703187D0 | Biodegradable drug delivery impact | |
| US2011053923A1 | Chemical compounds 610 | |
| CN101208304A | Quinoline 3-sulfonate esters as NK3 receptor modulators | |
| NZ528999A | An assay for detecting inhibitors of the enzyme myeloperoxidase and as a diagnostic test | |
| GB0119473D0 | Compounds | |
| GB0117900D0 | Chemical compounds |